Allosteric modulation of 5-HT3 receptors: Focus on alcohols and anaesthetic agents

Trends in Pharmacological Sciences

Volumn 17, Issue 3, 1996, Pages 95-99

  Parker, Rachel M C ^a   Bentley, Kim R ^a   Barnes, Nicholas M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,2 TRIFLUOROCYCLOBUTANE; 2 METHYLSEROTONIN; ALCOHOL; ALCOHOL DERIVATIVE; ALFAXALONE; ANESTHETIC AGENT; BUPIVACAINE; BUTANOL; CHLORAL HYDRATE; COCAINE; ETOMIDATE; GRANISETRON; HALOTHANE; ISOFLURANE; KETAMINE; LIDOCAINE; METHANOL; METHOHEXITAL; PENTANOL; PROCAINE; PROPANOL; PROPOFOL; QUIPAZINE; SEROTONIN; SEROTONIN 3 RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; TETRACAINE; THIOPENTAL; TRICHLOROETHANOL; TRIFLUOROETHANOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLOSTERISM; ANESTHESIA; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; NAUSEA; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VOMITING;

EID: 0030007504     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-6147(96)10003-1     Document Type: Article

References (38)

1. Boess, F. G. and Martin, I. L. (1994) Neuropharmacology 33, 275-317
2. Boess, F. G., Lummis, S. C. R. and Martin, I. L. (1992) J. Neurochem. 59, 1692-1701
3. Hope, A. G. et al. (1993) Eur. J. Pharmacol.-Mol. Pharmacol. Sect. 245, 187-192
4. Maricq, A. V., Peterson, A. S., Brake, A. J., Myers, R. M. and Julius, D. (1991) Science 254, 432-437
5. Isenberg, K. E. et al. (1993) NeuroReport 5, 121-124
6. Belilli, D. et al. (1995) Mol. Pharmacol. 48, 1054-1062
7. Miyake, A., Mochizuki, S., Takemoto, Y. and Akuzawa, S. (1995) Mol. Pharmacol. 48, 407-416
8. Bentley, K. R. and Barnes, N. M. (1995) CNS Drugs 3, 363-392
9. Peters, J. A., Malone, H. M. and Lambert, J. J. (1992) Trends Pharmacol. Sci. 13, 391-397
10. Grant, K. A. (1995) Drug Alcohol Depend. 38, 155-171
11. Miller, K. W. et al. (1991) in Molecular and Cellular Mechanisms of Alcohol and Anesthetics (Rubin, E., Miller, K. W. and Roth, S. H., eds), pp. 600-615, New York Academy of Sciences
12. Lovinger, D. M. and Peoples, R. W. (1993) in Alcohol, Cell Membrane and Signal Transduction in Brain: Proceedings of the Marcus Wallenberg Symposium (Alling, C., Diamond, I., Leslie, S. and Wood, W. G., eds), pp. 157-168, Plenum Press
13. Barann, M., Ruppert, K., Göthert, M. and Bönisch, H. (1995) Naunyn-Schmied. Arch. Pharmacol. 352, 149-156
14. Lovinger, D. M. and White, G. (1991) Mol. Pharmacol. 40, 263-270
15. Lovinger, D. M. and Zhou, Q. (1994) Neuropharmacology 33, 1567-1572
16. Machu, T. K. and Harris, R. A. (1994) J. Pharmacol. Exp. Ther. 271, 898-905
17. Hellevuo, K., Hoffman, P. L. and Tabakoff, B. (1991) Alcohol. Clin. Exp. Res. 15, 775-778
18. Emerit, M. B., Riad, M., Fattaccini, C. M. and Hamon, M. (1993) J. Neurochem. 60, 2059-2067
19. Göthert, M., Duhrsen, U. and Rieckesmann, J. M. (1979) Arch. Int. Pharmacodyn. Ther. 242, 196-209
20. Wafford, K. A. et al. (1991) Neuron 7, 27-33
21. Breimer, D. D. (1977) Clin. Pharmacokinet. 2, 93-109
22. Lovinger, D. M. and Zhou, Q. (1993) J. Pharmacol. Exp. Ther. 265, 771-776
23. Zhou, Q. and Lovinger, D. (1994) Biophys. J. 66, A436
24. Downie, D. L. et al. (1995) Br. J. Pharmacol. 114, 1641-1651
25. Ireland, S. J. and Tyers, M. B. (1987) Br. J. Pharmacol. 90, 229-238
26. Barnes, J. M. et al. (1992) Br. J. Pharmacol. 105, 500-504
27. Bentley, K. R., Johnston, K. D., Stowe, R. L. and Barnes, N. M. (1995) Br. J. Pharmacol. 116, 231P
28. Malinowska, B. et al. (1995) Eur. J. Pharmacol.-Environ. Toxicol. Pharmacol. Sect. 293, 71-76
29. Gill, C., Lambert, J. J. and Peters, J. A. (1994) Can. J. Physiol. Pharmacol. 72 (Suppl.) p18.4.24
30. Bufton, K. E., Steward, L. J., Barber, P. C. and Barnes, N. M. (1993) Neuropharmacology 32, 1325-1332
31. Franks, N. P. and Lieb, W. R. (1987) Trends Pharmacol. Sci. 8, 169-174
32. Peters, J. A., Malone, H. M. and Lambert, J. J. (1991) Br. J. Pharmacol. 103, 1623-1625
33. White, P. F., Way, W. L. and Trevoe, A. J. (1982) Anesthesiology 56, 119-136
34. Barann, M., Göthert, M., Fink, K. and Bönisch, H. (1993) Naunyn-Schmied. Arch. Pharmacol. 347, 125-132
35. Fozard, J. R., Mobarok Ali, A. T. M. and Newgrosh, G. (1979) Eur. J. Pharmacol. 59, 195-210
36. Fan, P. and Weight, F. F. (1994) Neuropharmacology 33, 1573-1579
37. Kooyman, A. R., van Hooft, J. A. Vanderheijden, P. M. L. and Vijverberg, H. P. M. (1994) Br. J. Pharmacol. 112, 541-546
38. Gill, C. H., Peters, J. A. and Lambert, J. J., (1995) Br. J. Pharmacol. 114, 1211-1221